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Abstract 
Purpose: To describe a pharmacist’s counseling service pertaining to methods of contraception on the postpartum unit of a  university 
hospital and to evaluate the number of postpartum patients who desire information on contraception with the demographics of age, 
public or private insurance, and whether the patient was English or Spanish-speaking. 
Methods: Retrospective cohort data analysis of postpartum women who received the option of counseling by a pharmacist or 
pharmacy intern at a university hospital over a year and 7 month period.  There were 2,048 cases included for this study. The total 
number of patients who wanted information as well as pharmacist preparation time and counseling time were also noted. 
Results: Patients who were interested in a hormonal contraception method were 3 times more likely to desire counseling compared 
with patients who declined information (p<0.05). Also, patients who wanted an implantable form of contraception were 8 times more 
likely to desire information compared with patients who declined counseling (p<0.05). Patients in the age range of 18-25, 26-30, and 
31-45 years were less likely (56%, 64%, & 65%) to want counseling compared with the age range of 12-17 years (all p<0.05). Lastly, 
patients who spoke Spanish were 3 times more likely to have been counseled compared with non-Spanish speaking patients. The 
number of postpartum patients counseled on different contraception methods was 1,546 versus 699 patients who declined 
counseling. Total pharmacist preparation time totaled 160.95 hours, while total patient counseling time totaled 204.55 hours.  
Conclusion: Overall, postpartum women who chose to be counseled by a pharmacist were considering either a hormonal or 
implantable method of contraception, were younger than the age of 17 and were Spanish speaking. The average amount of 
pharmacist preparation time spent was 4.3 minutes per patient and actual counseling time on average was 5.5 minutes per patient.  
 
 
Introduction 
Choosing a method of postpartum contraception is an 
important process for a woman. There are numerous reasons 
for having a sound method of birth control during this period, 
only a few of which include preventing short interval 
pregnancies, those that occur within 6 months of the 
previous birth, and negative socioeconomic outcomes. To 
better protect mothers and babies, it is vital to avoid short 
inter-pregnancy intervals which have been associated with 
increased infant mortality as well as increased risks to 
maternal health
1
. Also, having a short interval pregnancy can 
increase stress on the mother and can lead to poor neonatal 
outcomes like intrauterine growth retardation and preterm  
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delivery
2
.  The Center for Disease Control analyzed data from 
a 2006 Pregnancy Risk Assessment and Monitoring System 
(PRAMS) report and found that 88% of postpartum women 
admit using at least one method of contraception, but only 
61.7% view that method as highly effective
3
. According to a 
study on women in Europe and America, those aged 25-44 
years are aware of a wide variety of contraception choices 
but are most familiar with either the oral contraceptive pill or 
the male condom. Consequently, those are the methods most 
commonly used
4
.  
 
Many factors contribute to whether or not a woman uses 
postpartum contraception and what type of method is 
selected. During the postpartum period, health care providers 
can evaluate the birth control needs of their patients. 
Physicians, nurses, and pharmacists are available to speak 
with patients, determine their specific desires for postpartum 
contraception, and then counsel the patient on key points 
about those methods. In addition, counseling sessions that 
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supplement oral information with high-quality written 
material have been shown to improve women’s satisfaction 
with postpartum counseling
5
. There are many approaches 
that a health care provider can take to supply postpartum 
women with contraception counseling, only a few of them 
include written material and one-on-one counseling sessions. 
 
Numerous issues can aide or impede an individual's use of 
contraceptive methods including future pregnancy intentions, 
physical and financial access to methods, quality of care pre- 
and post-partum, specific attitudes towards methods and 
personal experience 
6
. Currently, the Affordable Care Act 
mandates that health care plans provide preventative care 
services that have been recommended by the Department of 
Health and Human Services and the Institute of Medicine. 
Contraceptive services are included in these preventative 
measures since they encourage the health and well-being of 
women
7
. The Contraceptive Health Research of Informed 
Choice Experience (CHOICE) study found that 47% of women 
who received counseling by their health care provider on 
multiple forms of combined hormonal contraceptives (pill, 
patch, and ring) selected a method different than the one 
they originally intended
8
. Specific factors identified as 
contributing to the choice of contraception method 
postpartum include age, private or public insurance, language 
and patient preference. Thus, it is important to understand 
demographic trends in contraception usage in order to 
improve access to methods of birth control for those who 
desire it.  
 
In our population at an urban University hospital, we 
observed that many patients want information about 
postpartum contraception. Our study evaluated patient 
demographics to determine if any trends existed that could 
allow a pharmacist to narrow who would most likely want 
postpartum counseling on forms of birth control. The time it 
took to perform the counseling service was also assessed. The 
pharmacist’s time in preparation for counseling patients and 
the actual time spent counseling patients were documented 
as well. Findings indicate there is little data on the 
effectiveness of counseling services in the postpartum 
community and no literature has been found on the 
importance of a pharmacist’s counseling service.  
 
Methods (study design and recruitment) 
This is a retrospective cohort data analysis of postpartum 
women who received the option of counseling by a 
pharmacist or pharmacy intern at the University of Alabama 
Hospital at Birmingham (UAB) over a period of 1 year and 7 
months. Postpartum status was defined as a woman of any 
age who had delivered a baby by vaginal or cesarean section 
who had not yet been discharged from the hospital. Potential 
study participants were identified from the hospital discharge 
log and included all women regardless of age, spoken 
language or insurance status. Since this process was 
performed during the normal scope of the pharmacists work 
day, no patients were excluded from being offered counseling 
and informed consent was not attained due to the 
retrospective nature of this data analysis. The pharmacist or 
intern documented the age and insurance status of the new 
mother as well as any pertinent patient information that 
would contraindicate certain contraception options (such as a 
history of a  deep vein thrombosis (DVT) preventing the use 
of estrogen containing contraception products 
9
). The 
pharmacist or intern then visited the woman in her hospital 
room to see if she would like information on various methods 
of contraception (oral contraceptive pill, ring, patch, 
injection, rod, or intra uterine device (IUD)). It was noted 
what method of contraception the patient wanted and if they 
accepted or declined counseling. The total number of 
patients who wanted information, pharmacist preparation 
time and actual counseling time were also noted. The 
pharmacist gave a general overview of the method and gave 
pamphlets on the birth control of interest. These pamphlets 
were available in English or Spanish.  
 
A data collection form was used to document the age, 
insurance, contraception method of interest and whether or 
not the patient was counseled. We investigated what 
methods were most utilized by specific age ranges, type of 
insurance and spoken language (English vs. Spanish-
speaking). The patients categorized by their demographics 
who utilized a pharmacist’s counseling service compared to 
those who did not were also analyzed. The analysis files for 
this study were created using excel spread sheet and all 
statistcal analysis were conducted using STATA version 13. A 
separate data collection form was used to document how 
many patients were counseled, how many patients were not 
counseled, the pharmacist preparation time and counseling 
time. Pharmacist preparation time included going through 
patient profiles to note patient demographics and to gain a 
sense of the patient’s medical history to make sure that they 
did not have any contraindications to certain methods of 
contraception (such as obesity, smoker, or prior history of 
DVT). Measures of central tendancy were used to compute 
averages regarding the total pharmacist preparation time and 
counseling time. The institutional review boards at Samford 
University and UAB Hospital approved this study. 
 
Results 
A total of 2,048 cases are included in this study. Beacuse of 
incomplete information (e.g. no insurance recorded or no 
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method of interest specified), 788 cases were excluded. 
Other cases were excluded due to outliers such as being 
Chinese; having Moyamoya disease; using natural family 
planning; preferring abstinence; using the Essure method; 
desiring bilateral tubal ligation or vasectomy; or due to 
religious reasons. Demographic characteristics of the patients 
are listed in Table 1. Of the 2,048 patients approached for 
counseling, 73.8% of them desired counseling by a 
pharmacist, while 26.2% declined it. The most popular form 
of contraception that patients wanted counseling on was 
hormonal methods (oral contraceptive pills, patch, ring, and 
injection) at 51.6%, 27.8% of patients wanted information on 
implantable forms of birth control (rod and IUD) and 20.6% 
wanted no information on any form of contraception. The use 
of barrier methods was not included in this study since 
pharmacists do not counsel on these particular forms. Table 1 
lists the demographic information of the study participants.  
 
According to the logistic regression analysis, patients who 
were interested in a hormonal contraception method were 3 
times more likely to desire counseling compared with 
patients who declined information (p<0.05). Also, patients 
who wanted an implantable form of contraception were 8 
times more likely to desire information compared with 
patients who declined counseling (p<0.05). Patients in the 
age range of 18-25, 26-30, and 31-45 years were less likely 
(56%, 64%, & 65%) to want counseling compared with the 
age range of 12-17 years (all p<0.05). Lastly, patients who 
spoke Spanish were 3 times more likely to have been 
counseled compared with non-Spanish speaking patients 
(p<0.05). All information is summarized in Table 2. 
 
The number of postpartum patients counseled on 
contraception methods over a 19 month period was 1,512 
versus 536 patients who declined counseling. Total 
pharmacist preparation before the counseling sessions 
totaled 160.95 hours, while total patient counseling totaled 
204.55 hours. The pharmacist spent on average 4.3 minutes 
per patient in preparation time and 5.5 minutes per patient in 
counseling time, giving a total of 9.8 minutes spent on each 
patient that was counseled.  
 
Discussion 
The number of patients who accepted counseling by a 
pharmacist is encouraging. By evaluating trends in this data, it 
would be useful for other hospitals to develop pharmacist 
counseling services to target younger patients and Spanish 
speaking patients for postpartum contraceptive counseling. 
One study from 2006 noted that more than 4 out of 5 
unintended pregnancies occurred in women 19 years of age 
or younger
10
. Pharmacists interested in counseling should be 
proficient in hormonal methods as well as implantable forms 
of birth control. There was no statistically significant 
difference between public or private insurance when it came 
to whether or not a patient wanted to be counseled. 
 
Overall, this research agrees with existing literature that 
health care providers must be proactive in addressing their 
patients’ birth control needs in the postpartum period 
6
. The 
postpartum period is an important time for underinsured, 
low-income and immigrant women to obtain contraception 
because of insurance coverage for those who might 
otherwise be unable to access the health-care system 
11
. 
Compared to black and white teenagers, Latina teenagers are 
less knowledgeable about methods of contraception. 
Therefore, it is important to recognize that the Latina 
population has a higher need for information about birth 
control 
12
. In addition, Latinas have less social support from 
family and friends when it comes to using contraception 
when compared to Caucasians
13
. Likewise, adolescents under 
the age of 18 should be targets for contraception counseling 
and follow-up since they are particularly at risk of 
discontinuing contraception. Reasons for discontinuation of 
contraception include termination of insurance coverage, 
difficulty in communicating with parents, and method 
switching which leads to gaps in use 
12
. Also, it is important to 
note that 10% of adolescent girls in the US become pregnant 
each year and among those who give birth, 16-30% of them 
are pregnant again within one year
14
.  
 
It is important for all health care providers to give accurate 
information about contraception that is specific to each 
patient’s particular desires. A Cochrane Database review 
found that many women who have just given birth feel they 
are provided contraception counseling “as part of a 
checklist.” Also, women may prefer to talk about birth control 
along with other health issues 
15
, which makes a pharmacist 
who is equipped with the knowledge of medicines, side 
effects, and different disease states a fantastic choice to meet 
these patients’ wishes. One study does bring up the issue that 
receiving contraceptive counseling postpartum does not 
necessarily lead to increased long-term use by patients. 
Recognizing this dilemma shows practitioners that more 
research is required to establish the optimal way of ensuring 
education and access to women after childbirth 
16
. 
Pharmacists may provide the information that is necessary to 
patients postpartum as well as supply unique counseling tools 
that may lead to better patient compliance. 
 
There are several limitations to this study. Due to staffing 
issues, not every single postpartum patient at the hospital 
during this time period was offered contraceptive counseling 
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by a pharmacist. In addition to staffing issues, the counseling 
service was not performed every day due to some days 
having an increased work load that required the pharmacists’ 
time. Also, there was variability in the pharmacist performing 
the counseling service as well as the patients who were 
counseled. The counseling service was only provided in 
English and Spanish. Furthermore, sometimes other health 
professionals had already counseled the patients or answered 
questions about contraception which eliminated the need for 
pharmacist counseling. This study does not evaluate whether 
or not the patient chose to start the contraceptive method 
discussed and also did not follow up with the patient to see if 
she was using a method 6 months postpartum. 
 
Conclusion 
In conclusion, postpartum women who chose to be counseled 
by a pharmacist were considering either a hormonal or 
implantable method of contraception, were younger than the 
age of 17 and were Spanish speaking. Furthermore, the 
average amount of pharmacist preparation time spent was 
4.3 minutes per patient and actual counseling time on 
average was 5.5 minutes per patient, totaling just less than 10 
minutes spent on each patient. This study shows that a 
counseling service could easily be incorporated into a 
pharmacist’s daily schedule on a postpartum hospital unit. 
These results could be recognized and applied to other 
counseling services and hospitals to benefit postpartum 
patients all over the country. 
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Table 1: Demographic characteristics of study participants 
 
Group Number of Women (%) 
Accepted counseling  
Yes 1,512 (73.8) 
No 536 (26.2) 
Contraception of choice  
Hormonal 
a
 1,058 (51.6) 
Implantable 
b
 569 (27.8) 
None 421 (20.6) 
Age range  
12-17 113 (5.5) 
18-25 1,069 (52.2) 
26-30 497 (24.3) 
31-45 369 (18.0) 
Type of insurance  
Public 
c
 1,526 (74.5) 
Private 
d
 417 (20.4) 
Dual 
e
 20 (1.0) 
None 85 (4.1) 
Language  
English 1,956 (95.5) 
Spanish 92 (4.5) 
              a 
Hormonal forms of contraception include oral contraceptive pills, patch, Nuvaring, and Depo Provera     
            injection. 
              b
 Implantable forms of contraception include the Implanon Rod and Mirena IUD. 
              c 
Public insurance includes Medicaid, Medicare, and Veteran’s Administration Tricare. 
              d 
Private insurance includes BCBS, Viva, United, and Cigna. 
              e
 Dual insurance includes patients who had both public and private insurance. 
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Table 2: Logistic regression analysis of individual predictors of accepting counseling among entire cohort 
 
Group Odds Ratio 95% CI P-value 
Contraception of choice    
None  Reference -- -- 
Hormonal  3.834 2.94-4.99 <0.05 
Implantable  8.493 6.06-11.90 <0.05 
Age range    
12-17 Reference -- -- 
18-25 .463 .261-.821 <0.05 
26-30 .364 .200-.662 <0.05 
31-45 .351 .191-.647 <0.05 
Type of insurance    
None Reference -- -- 
Public  .641 .349-1.176 0.151 
Private  .584 .307-1.112 0.101 
Dual  .653 .187-2.267 1.502 
Language    
English Reference -- -- 
Spanish 3.729 1.755-7.923 <0.05 
 
 
